Panjon Ltd
Incorporated in 1983, Panjon Ltd manufactures and trades consumer and pharmaceutical products
- Market Cap ₹ 41.6 Cr.
- Current Price ₹ 24.2
- High / Low ₹ 30.0 / 16.1
- Stock P/E 54.7
- Book Value ₹ 9.88
- Dividend Yield 0.00 %
- ROCE 4.00 %
- ROE 2.55 %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
- Debtor days have improved from 61.7 to 39.1 days.
- Company's working capital requirements have reduced from 267 days to 105 days
Cons
- Company has a low return on equity of 3.17% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19.29 | 19.47 | 12.26 | 13.98 | 20.10 | 25.94 | 26.43 | 14.49 | 8.41 | 6.09 | 12.55 | 30.46 | 49.34 | |
| 19.15 | 22.54 | 12.35 | 14.00 | 19.68 | 25.63 | 26.11 | 14.30 | 12.45 | 6.09 | 12.57 | 29.83 | 48.29 | |
| Operating Profit | 0.14 | -3.07 | -0.09 | -0.02 | 0.42 | 0.31 | 0.32 | 0.19 | -4.04 | 0.00 | -0.02 | 0.63 | 1.05 |
| OPM % | 0.73% | -15.77% | -0.73% | -0.14% | 2.09% | 1.20% | 1.21% | 1.31% | -48.04% | 0.00% | -0.16% | 2.07% | 2.13% |
| 0.02 | -1.51 | 0.43 | 0.52 | 0.21 | 0.36 | 0.29 | 0.33 | 0.30 | 0.38 | 0.45 | 0.31 | 0.18 | |
| Interest | 0.00 | 0.00 | 0.17 | 0.19 | 0.28 | 0.24 | 0.15 | 0.10 | 0.07 | 0.05 | 0.06 | 0.18 | 0.23 |
| Depreciation | 0.08 | 0.13 | 0.14 | 0.13 | 0.11 | 0.15 | 0.27 | 0.23 | 0.20 | 0.21 | 0.22 | 0.23 | 0.24 |
| Profit before tax | 0.08 | -4.71 | 0.03 | 0.18 | 0.24 | 0.28 | 0.19 | 0.19 | -4.01 | 0.12 | 0.15 | 0.53 | 0.76 |
| Tax % | 312.50% | -27.18% | -1,133.33% | 33.33% | 50.00% | 53.57% | 115.79% | 47.37% | 3.49% | -575.00% | 0.00% | 24.53% | |
| -0.17 | -3.43 | 0.36 | 0.12 | 0.12 | 0.14 | -0.03 | 0.10 | -4.15 | 0.81 | 0.15 | 0.40 | 0.76 | |
| EPS in Rs | -0.11 | -2.21 | 0.23 | 0.08 | 0.08 | 0.09 | -0.02 | 0.06 | -2.68 | 0.52 | 0.09 | 0.23 | 0.44 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 3% |
| 3 Years: | 54% |
| TTM: | 126% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 73% |
| 3 Years: | 28% |
| TTM: | 117% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 28% |
| 1 Year: | 10% |
| Return on Equity | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -4% |
| 3 Years: | 3% |
| Last Year: | 3% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 15.50 | 15.50 | 15.50 | 15.50 | 15.50 | 15.50 | 15.50 | 15.50 | 15.50 | 15.50 | 16.31 | 17.17 | 17.17 |
| Reserves | 8.85 | 0.52 | 0.89 | 1.00 | 1.13 | 1.27 | 1.23 | 1.31 | -2.84 | -2.02 | -1.46 | -0.62 | -0.21 |
| 1.67 | 1.52 | 1.41 | 1.26 | 1.89 | 1.84 | 1.56 | 1.33 | 0.81 | 0.78 | 1.44 | 2.65 | 3.55 | |
| 1.39 | 0.51 | 0.24 | 0.28 | 0.29 | 0.34 | 0.92 | 1.12 | 0.58 | 0.64 | 1.10 | 0.85 | 1.02 | |
| Total Liabilities | 27.41 | 18.05 | 18.04 | 18.04 | 18.81 | 18.95 | 19.21 | 19.26 | 14.05 | 14.90 | 17.39 | 20.05 | 21.53 |
| 5.69 | 0.92 | 0.84 | 0.74 | 0.72 | 0.87 | 1.12 | 0.96 | 0.95 | 0.91 | 0.90 | 1.09 | 1.24 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 1.18 | 1.08 | 1.08 | 1.08 | 1.09 | 1.09 | 1.08 | 1.07 | 1.07 | 1.08 | 1.08 | 1.10 | 1.10 |
| 20.54 | 16.05 | 16.12 | 16.22 | 17.00 | 16.99 | 17.01 | 17.23 | 12.03 | 12.91 | 15.41 | 17.86 | 19.19 | |
| Total Assets | 27.41 | 18.05 | 18.04 | 18.04 | 18.81 | 18.95 | 19.21 | 19.26 | 14.05 | 14.90 | 17.39 | 20.05 | 21.53 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.48 | 0.89 | -0.20 | 0.18 | -0.17 | 0.49 | 0.35 | 0.34 | 1.82 | 0.04 | -0.42 | -4.34 | |
| -0.10 | 4.74 | -0.06 | -0.04 | -0.08 | -0.31 | -0.51 | -0.06 | -0.19 | -0.19 | -0.21 | -0.44 | |
| 3.44 | -5.14 | -0.19 | -0.17 | 0.40 | -0.05 | -0.07 | -0.24 | -0.51 | 0.18 | 1.88 | 2.50 | |
| Net Cash Flow | -0.14 | 0.49 | -0.44 | -0.03 | 0.15 | 0.13 | -0.22 | 0.04 | 1.12 | 0.04 | 1.25 | -2.27 |
| Free Cash Flow | -3.58 | 5.54 | -0.26 | 0.14 | -0.25 | 0.18 | -0.17 | 0.27 | 1.63 | -0.14 | -0.62 | -4.76 |
| CFO/OP | -2,471% | -29% | 222% | -1,100% | -29% | 177% | 122% | 195% | -45% | 2,100% | -689% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 241.44 | 184.28 | 261.39 | 21.67 | 16.89 | 23.64 | 45.57 | 93.45 | 26.47 | 93.50 | 52.64 | 39.06 |
| Inventory Days | 117.88 | 46.16 | 101.43 | 95.13 | 66.63 | 57.65 | 59.10 | 120.11 | 306.47 | 610.67 | 152.35 | 65.87 |
| Days Payable | 12.18 | 7.20 | 4.14 | 2.93 | 2.19 | 3.98 | 11.48 | 28.24 | 19.51 | 63.17 | 6.93 | 3.56 |
| Cash Conversion Cycle | 347.14 | 223.24 | 358.68 | 113.87 | 81.33 | 77.31 | 93.20 | 185.32 | 313.43 | 641.00 | 198.07 | 101.37 |
| Working Capital Days | 336.43 | 262.83 | 428.41 | 177.80 | 123.85 | 112.85 | 138.51 | 261.22 | 277.76 | 480.07 | 216.38 | 105.45 |
| ROCE % | 0.33% | -14.51% | 1.13% | 2.08% | 2.87% | 2.80% | 1.84% | 1.59% | -24.93% | 1.23% | 1.37% | 4.00% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Manufacturing Sales INR Hundreds |
|
||||||||||
| Trading Sales INR Hundreds |
|||||||||||
| Number of Permanent Employees Number |
|||||||||||
| Trade Receivables Turnover Ratio Percentage |
|||||||||||
| Geography-wise Revenue: Central INR Hundreds |
|||||||||||
| Geography-wise Revenue: West INR Hundreds |
|||||||||||
Documents
Announcements
- Closure of Trading Window 25 Mar
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
14 Feb - ENCLOSED HEREWITH UNAUDITED FINACIAL RESULT FOR THE QUARTER ENDED 31/12/2025 IN NEWSPAPER
-
Board Meeting Outcome for BOARD MEETING DATED 13/02/2026
13 Feb - Approved Q3/9M results; 8,97,706 warrants lapsed; 25% subscription forfeited; limited review dated 13-Feb-2026.
-
UNAUDITED FINANCIAL RESULTS FOR QUARTER ENDED 31/12/2025
13 Feb - Approved unaudited financial results for quarter and nine months ended 31 Dec 2025; board met 13 Feb 2026.
-
Board Meeting Intimation for BOARD MEETING DATED 13/02/2026
7 Feb - Board meeting on 13 Feb 2026 to approve un-audited Q and nine-month results ended 31 Dec 2025.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Product Profile:[1][2]
Panjon Tablet, Panjon Balm, Panjon Cough Syrup, Panjon Cough Drops, Panjon Inhaler, Hinkargiri Hair Oil, Kery, Percy, Swad, Swad Awla, Swad Khajoor, Swad Chatpati, Swad Shoppee, Swad Energy Drink, Panjon Dental Cream, Purti Mouth Freshner
Distribution Network:[3]
Company markets and manufactures its products and undertakes contract manufacturing for MNCs. Company sells its formulations under own brand name, through a nationwide marketing network of 20+ states through a chain of 80 distributors who in turn sell goods to 1000 appointed stockiest and 4,50,000 retailers, with help of a field force of 300+ sales representatives